- Home
- PRTA vs ACNB Comparison
PRTA vs ACNB Comparison
Compare PRTA & ACNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRTA | ACNB |
|---|---|---|
| Founded | 2012 | 1857 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.3M | 522.8M |
| IPO Year | 2013 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PRTA | ACNB |
|---|---|---|
| Price | $9.31 | $46.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | $19.00 | ★ $49.50 |
| AVG Volume (30 Days) | ★ 416.4K | 30.2K |
| Earning Date | 05-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.24% |
| EPS Growth | N/A | ★ 0.54 |
| EPS | N/A | ★ 2.56 |
| Revenue | $814,000.00 | ★ $132,195,000.00 |
| Revenue This Year | $1,111.38 | $13.18 |
| Revenue Next Year | N/A | $1.91 |
| P/E Ratio | ★ N/A | $18.31 |
| Revenue Growth | N/A | ★ 14.87 |
| 52 Week Low | $4.32 | $35.70 |
| 52 Week High | $14.34 | $53.89 |
Technical Indicators
Market Signals| Indicator | PRTA | ACNB |
|---|---|---|
| Relative Strength Index (RSI) | 49.36 | 31.98 |
| Support Level | $9.07 | $41.86 |
| Resistance Level | $9.59 | $46.53 |
| Average True Range (ATR) | 0.50 | 1.65 |
| MACD | 0.05 | -0.53 |
| Stochastic Oscillator | 44.96 | 10.82 |
Price Performance
Historical ComparisonAbout PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.